Home Tools
Log in
Cart

Search Result

Search Results for " bioavailability "

20

Compounds

Cat No. Product Name Synonyms Targets
T2086 ELN-441958 ELN 441958 Bradykinin Receptor
ELN-441958 is a potent, neutral antagonist of B1 receptor, inhibits the binding of the B1 agonist ligand [3H]DAKD to IMR-90 cells with Ki of 0.26 nM. ELN-441958(ELN 441958) is highly selective for B1 over B2 receptors.
T1770 GNE-9605 LRRK2
GNE-9605 is a highly effective, specifical, and brain-penetrant LRRK2 inhibitor (IC50: 19 nM).
T13099 TC ASK 10 ASK , MAPK
TC ASK 10 is a potent, selective and orally active inhibitor of apoptosis signal-regulating kinase 1 (ASK1)(IC50 of 14 nM).
T10606 BRD0705 GSK-3
BRD0705 is a potent, paralog selective and orally active GSK3α inhibitor (IC50: 66 nM; Kd: 4.8 μM). BRD0705 displays increased selectivity for GSK3α (8-fold) versus GSK3β (IC50: 515 nM).
TQ0239 PF-06291874 Glucagon receptor antagonists-4 Glucagon Receptor
PF-06291874 (Glucagon receptor antagonists-4) (Glucagon receptor antagonists-4) is a highly effective and orally active antagonist of the glucagon receptor.
T24493 Monoelaidin
Monoelaidin is a poorly water-soluble drug enhancer of solubility and oral bioavailability.
T8160 EGCG Octaacetate Others , Antibacterial
EGCG Octaacetate, a prodrug of EGCG, is utilized to enhance the stability and bioavailability of EGCG in vivo. It has high efficacy, bioavailability, anti-oxidation, and anti-angiogenesis capacities.
T69757 PDDC inhibitor
PDDC is the first nSMase2 inhibitor that possesses both favorable pharmacodynamics and pharmacokinetic (PK) parameters, including substantial oral bioavailability, brain penetration, and significant inhibition of exosome...
T19609 HP-β-CD Hydroxypropyl-β-cyclodextrin,Hydroxypropyl betadex Others
HP-β-CD (HP-β-CD) is a widely used drug delivery vehicle to improve stability and bioavailability.
T9173 HM-30181 mesylate monohydrate P-gp
HM-30181 mesylate monohydrate is an oral P-glycoprotein (P-gp) inhibitor, used to enhance the oral bioavailability of P-gp substrate drugs.
T15409 GNF179 Parasite
GNF179 is an optimized 8,8-dimethyl IP analog. It exhibited the potency(4.8 nM against the multidrug resistant strain W2) in vitro metabolic stability and in vivo oral bioavailability.
T8850 Sbp-7455 Autophagy
SBP-7455 potently inhibited ULK1/2 enzymatic activity in vitro and in cells, reduced the viability of TNBC cells and had oral bioavailability in mice.
T7614 Eniluracil GW776C85,5-Ethynyluracil Others
Eniluracil (GW776C85) is an orally activedihydropyrimidine dehydrogenase (DPD) inhibitor,increases the oral bioavailability of 5-FU to 100%, facilitating uniform absorption and predictable toxicity.
TQ0039 (±)-Zanubrutinib (±)-BGB-3111 BTK
(±)-Zanubrutinib ((±)-BGB-3111) is a potent and orally available Bruton's tyrosine kinase (Btk) inhibitor that demonstrates superior oral bioavailability, achieving higher exposure and more complete target inhibi.
T7897 PK150 Others , Antibacterial
PK150 shows oral bioavailability and antibacterial activity against several pathogenic strains at submicromolar concentrations.
T26863 BMS-929075 BMS 929075,BMS929075 HCV Protease
BMS-929075 is an orally active HCV NS5B replicase (HCV NS5B replicase) palm site variant inhibitor with potency, high oral bioavailability and pharmacokinetic parameters.BMS-929075 shows cytotoxicity.
T9692 Paltusotine Somatostatin
Paltusotine is a nonpeptide, small molecule somatostatin type 2 (SST2) receptor agonist with high oral bioavailability. Paltusotine maintains GH and IGF-1 levels in acromegaly patients
T16143 MRTX-1257 Ras
MRTX-1257 is a selective, irreversible, and covalent inhibitor of KRAS G12C. It has an IC50 of 900 pM for KRAS dependent ERK phosphorylation in H358 cells. MRTX1257 demonstrated 31% bioavailability in the mouse, with fre...
T3312 AM-2394 AM2394 Glucokinase
AM-2394 is an effective and specific Glucokinase agonist (GKA, EC50: 60 nM), which catalyzes the phosphorylation of glucose to glucose-6-phosphate. AM-2394(AM2394) increases the affinity of GK for glucose by approximatel...
T24480 MK-8325 MK 8325,MK8325 HCV Protease
MK-8325 is a potent and orally available HCV NS5A inhibitor with replicative activity against a wide range of genotypes.MK-8325 has demonstrated bioavailability in in vitro and in vivo assays and has a favorable overall ...
1 2 3 4 5 6 7 8
TargetMol